Saverna Therapeutics
Pre-clinicalAt Saverna Therapeutics we use a platform based on the latest Artificial Intelligence tools and Nuclear Magnetic Resonance to reduce the time and costs of drug discovery.
Founded
2017
Focus
Small Molecules
About
At Saverna Therapeutics we use a platform based on the latest Artificial Intelligence tools and Nuclear Magnetic Resonance to reduce the time and costs of drug discovery.
Funding History
1Total raised: $11M
Seed$11MNovo HoldingsJan 15, 2023
Company Info
TypePrivate
Founded2017
LocationBasel, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile